GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avivagen Inc (OTCPK:VIVXF) » Definitions » Total Current Assets

Avivagen (Avivagen) Total Current Assets : $0.17 Mil (As of Jul. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Avivagen Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Avivagen's total current assets for the quarter that ended in Jul. 2023 was $0.17 Mil.


Avivagen Total Current Assets Historical Data

The historical data trend for Avivagen's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avivagen Total Current Assets Chart

Avivagen Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.34 1.30 1.35 2.59 0.93

Avivagen Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.19 0.93 0.37 0.20 0.17

Avivagen Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Avivagen's Total Current Assets for the fiscal year that ended in Oct. 2022 is calculated as

Avivagen's Total Current Assets for the quarter that ended in Jul. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.


Avivagen  (OTCPK:VIVXF) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Avivagen's Liquidation Value for the quarter that ended in Jul. 2023 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.013-7.22+0.75 * 0.027+0.5 * 0.056
=-7.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avivagen Total Current Assets Related Terms

Thank you for viewing the detailed overview of Avivagen's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Avivagen (Avivagen) Business Description

Traded in Other Exchanges
Address
100 Sussex Drive, Ottawa, ON, CAN, K1A 0R6
Avivagen Inc is a Canadian-based company operating in the healthcare sector. It develops science-based, natural health products for animals. It develops and commercializes products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal's health defenses. The company's products are based on OxC-beta Technology. Its geographical segments include the Philippines, which is the key revenue driver; Mexico; Thailand; United States; Malaysia; Taiwan; Brazil; and others.

Avivagen (Avivagen) Headlines

From GuruFocus

Avivagen to Pursue Regulatory Approval in Mexico

By Marketwired Marketwired 05-25-2018

Avivagen Retains ITG to Conduct Market Making Activities

By Marketwired Marketwired 10-02-2018

Avivagen Announces Distribution Agreement in Thailand

By Marketwired Marketwired 06-13-2018

Avivagen Announces Vivamune Distribution Agreement for the GTA

By Marketwired Marketwired 08-22-2018

Avivagen Inc. Announces Change of Auditor

By Marketwired Marketwired 01-04-2019

Avivagen Announces CEO Letter to Shareholders

By Marketwired Marketwired 01-17-2019